MITA lukewarm on CMS' PET decision
Article Thumbnail ImageOctober 1, 2013 -- The Medical Imaging and Technology Alliance (MITA) cited progress in the U.S. Centers for Medicare and Medicaid Services' (CMS) final decision on beta-amyloid PET coverage; however, the organization said it was disappointed by the scope.

To get access to this article and all of the content on, create a free account or sign-in now.

Member Sign In:
  MemberID or E-mail Address:

New Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • On September 27, CMS issued a final decision approving beta-amyloid PET under the agency's coverage with evidence development (CED) protocol for patients enrolled in an approved clinical study.

    Although MITA appreciates that CMS is offering beta-amyloid PET to some Medicare beneficiaries, the group is disappointed there will not be coverage for beta-amyloid PET without CED for patients with suspected dementia or Alzheimer's disease who meet specific appropriate-use criteria.

    The organization will continue to work with CMS toward a substantive, feasible CED program that will support broader access for Medicare patients, according to Gail Rodriguez, executive director of MITA.

    || About || Advertising || || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 All Rights Reserved.